507 related articles for article (PubMed ID: 37900996)
21. Exosomal miRNAs assist in the crosstalk between tumor cells and immune cells and its potential therapeutics.
Chen X; Li Y; Li M; Xie Y; Wang K; Zhang L; Zou Z; Xiong L
Life Sci; 2023 Sep; 329():121934. PubMed ID: 37460057
[TBL] [Abstract][Full Text] [Related]
22. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
[TBL] [Abstract][Full Text] [Related]
23. Exosomal linc-FAM138B from cancer cells alleviates hepatocellular carcinoma progression via regulating miR-765.
Zhuo C; Yi T; Pu J; Cen X; Zhou Y; Feng S; Wei C; Chen P; Wang W; Bao C; Wang J; Tang Q
Aging (Albany NY); 2020 Dec; 12(24):26236-26247. PubMed ID: 33401249
[TBL] [Abstract][Full Text] [Related]
24. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway.
Xia Y; Zhen L; Li H; Wang S; Chen S; Wang C; Yang X
Cell Death Dis; 2021 Mar; 12(4):326. PubMed ID: 33771969
[TBL] [Abstract][Full Text] [Related]
25. Advances in Exosomal microRNAs and Proteins in Ovarian Cancer Diagnosis, Prognosis, and Treatment.
Qin T; Chen F; Zhu J; Ding Y; Zhang Q
Curr Mol Med; 2023; 23(6):509-520. PubMed ID: 35770407
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
[TBL] [Abstract][Full Text] [Related]
27. Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma.
Zhang Q; Li H; Liu Y; Li J; Wu C; Tang H
Curr Oncol; 2022 Jul; 29(8):5383-5406. PubMed ID: 36005165
[TBL] [Abstract][Full Text] [Related]
28. Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression.
Chen W; Quan Y; Fan S; Wang H; Liang J; Huang L; Chen L; Liu Q; He P; Ye Y
Cancer Lett; 2020 Apr; 475():119-128. PubMed ID: 32014458
[TBL] [Abstract][Full Text] [Related]
29. Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.
Fanale D; Corsini LR; Bono M; Randazzo U; Barraco N; Brando C; Cancelliere D; Contino S; Giurintano A; Magrin L; Pedone E; Perez A; Piraino P; Pivetti A; Giovanni ED; Russo TDB; Prestifilippo O; Gennusa V; Pantuso G; Russo A; Bazan V
Crit Rev Oncol Hematol; 2024 Jan; 193():104220. PubMed ID: 38036154
[TBL] [Abstract][Full Text] [Related]
30. Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance.
Santos P; Almeida F
Cells; 2020 Jun; 9(6):. PubMed ID: 32545155
[TBL] [Abstract][Full Text] [Related]
31. An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment.
Xu HZ; Lin XY; Xu YX; Xue HB; Lin S; Xu TW
Front Immunol; 2023; 14():1227150. PubMed ID: 37753074
[TBL] [Abstract][Full Text] [Related]
32. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
Fu X; Liu M; Qu S; Ma J; Zhang Y; Shi T; Wen H; Yang Y; Wang S; Wang J; Nan K; Yao Y; Tian T
J Exp Clin Cancer Res; 2018 Mar; 37(1):52. PubMed ID: 29530052
[TBL] [Abstract][Full Text] [Related]
33. Potential biomarkers in NASH-induced liver cirrhosis with hepatocellular carcinoma: A preliminary work on roles of exosomal miR-182, miR-301a, and miR-373.
Muhammad Yusuf AN; Raja Ali RA; Muhammad Nawawi KN; Mokhtar NM
Malays J Pathol; 2020 Dec; 42(3):377-384. PubMed ID: 33361718
[TBL] [Abstract][Full Text] [Related]
34. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
[TBL] [Abstract][Full Text] [Related]
35. Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma.
Sorop A; Constantinescu D; Cojocaru F; Dinischiotu A; Cucu D; Dima SO
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066780
[TBL] [Abstract][Full Text] [Related]
36. miR-125a/b inhibits tumor-associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90.
Wang Y; Wang B; Xiao S; Li Y; Chen Q
J Cell Biochem; 2019 Mar; 120(3):3046-3055. PubMed ID: 30536969
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma.
Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W
J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733
[TBL] [Abstract][Full Text] [Related]
38. Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer.
Wang H; Lu Z; Zhao X
J Hematol Oncol; 2019 Dec; 12(1):133. PubMed ID: 31815633
[TBL] [Abstract][Full Text] [Related]
39. Exosome-transmitted long non-coding RNA
Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
Aging (Albany NY); 2020 Jun; 12(12):11550-11567. PubMed ID: 32602848
[TBL] [Abstract][Full Text] [Related]
40. Extracellular Vesicles-Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation.
Baldari S; Di Rocco G; Magenta A; Picozza M; Toietta G
Cells; 2019 Dec; 8(12):. PubMed ID: 31816923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
